Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
NCT00573794
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
592
Enrollment
INDUSTRY
Sponsor class
Conditions
Ulcerative Colitis
Interventions
BIOLOGICAL:
adalimumab
Sponsor
AbbVie (prior sponsor, Abbott)